If you are uncertain about the appropriate angle, consult your healthcare provider or diabetes care and education specialist (CDCES)
(1992) 263(2 Pt 1):G174G180 2
EG is a paid consultant for Novartis, Flare Therapeutics, Reactive Biosciences and Seagen, and receives grant support from NIH/NCI R37CA266853 and NIH/NHLBI R38HL172261
For insulin syringes with integrated needles, this dead volume is typically 0.5-2 units
They are not intended for short-term or cosmetic weight loss
Compounded Semaglutide & Tirzepatide in 2026: FDA Rules, Safety Risks, and How to Choose a Legitimate Pharmacy Joshua Silva, MD Oct 3, 2025 5 min read Updated: Jan 21 Medically authored by Joshua Silva, MD | Evidence-Based Weight Loss at Potere Health MD As of 2026, compounded semaglutide and tirzepatide are no longer broadly permitted in the United States